Cervical cancers avoided by HPV immunisation

Maggie Cruickshank; Mihaela  Grigore

doi:10.1016/S0140-6736(21)02396-5

Cervical cancers avoided by HPV immunisation

Maggie Cruickshank^* (Corresponding Author), Mihaela Grigore

^*Corresponding author for this work

University of Medicine and Pharmacy

Research output: Contribution to journal › Comment/debate › peer-review

4 Citations (Scopus)

Abstract

In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, 1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.

Original language	English
Pages (from-to)	P2053-2055
Number of pages	3
Journal	The Lancet
Volume	398
Issue number	10361
Early online date	3 Nov 2021
DOIs	https://doi.org/10.1016/S0140-6736(21)02396-5
Publication status	Published - 4 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(21)02396-5Licence: Unspecified

Cite this

@article{0e6e20524f7b41b6b0b570f453feade2,

title = "Cervical cancers avoided by HPV immunisation",

abstract = "In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, 1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.",

author = "Maggie Cruickshank and Mihaela Grigore",

year = "2021",

month = dec,

day = "4",

doi = "10.1016/S0140-6736(21)02396-5",

language = "English",

volume = "398",

pages = "P2053--2055",

journal = "The Lancet",

issn = "0140-6736",

publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

number = "10361",

}

TY - JOUR

T1 - Cervical cancers avoided by HPV immunisation

AU - Cruickshank, Maggie

AU - Grigore, Mihaela

PY - 2021/12/4

Y1 - 2021/12/4

N2 - In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, 1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.

AB - In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem, 1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.

U2 - 10.1016/S0140-6736(21)02396-5

DO - 10.1016/S0140-6736(21)02396-5

M3 - Comment/debate

SN - 0140-6736

VL - 398

SP - P2053-2055

JO - The Lancet

JF - The Lancet

IS - 10361

ER -

Cervical cancers avoided by HPV immunisation

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this